Creative Medical Technology (CELZ) News Today $4.88 +0.75 (+18.16%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$4.82 -0.06 (-1.23%) As of 10/24/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Creative Medical Technology Holdings Congratulates Nobel Laureates and Highlights Recent Patents for ImmCelz™ PlatformOctober 7, 2025 | quiverquant.comQCreative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell BreakthroughsOctober 7, 2025 | globenewswire.comCreative Medical Technology Holdings Inc (CELZ) - Investing.comAugust 23, 2025 | investing.comRetail Traders Pile Into Creative Medical After FDA Fast Tracks Degenerative Disc Disease TherapyAugust 14, 2025 | msn.comCreative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back PainAugust 13, 2025 | tmcnet.comCreative Medical Technology Holdings Second Quarter 2025 Earnings: US$0.48 loss per share (vs US$1.11 loss in 2Q 2024)August 11, 2025 | finance.yahoo.comCourtney Bartlett - CELZ | Creative Medical Technology Holdings Inc ...July 17, 2025 | wsj.comCreative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune CellsJuly 17, 2025 | finance.yahoo.comCreative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune CellsJuly 17, 2025 | globenewswire.comCreative Medical Technology Holdings Receives Notice of Allowance for ...July 13, 2025 | seekingalpha.comCreative Medical Technology Holdings, Inc.: Creative Medical Technology Holdings Receives Notice of Allowance for ImmCelz for Treatment of Heart Failure and/or Post Infarct ...July 12, 2025 | finanznachrichten.deCreative Medical Technology Holdings Receives Notice of Allowance for ImmCelz™ for Treatment of Heart Failure and/or Post Infarct Pathological RemodelingJuly 11, 2025 | globenewswire.comCELZ Creative Medical Technology Holdings, Inc. - Seeking AlphaJune 28, 2025 | seekingalpha.comCreative Medical Technology Holdings: Initiating Coverage With A Sell RatingMay 12, 2025 | seekingalpha.comCompanies Like Creative Medical Technology Holdings (NASDAQ:CELZ) Are In A Position To Invest In GrowthApril 27, 2025 | finance.yahoo.comCreative Medical Technology files to sell 1.8M shares of common for holdersApril 3, 2025 | markets.businessinsider.comCreative Medical Technology price target lowered to $26 from $30 at Roth MKMMarch 22, 2025 | markets.businessinsider.comCreative Medical secures FDA clearance for dose escalation in Phase 1/2 trialMarch 21, 2025 | markets.businessinsider.comCreative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back PainMarch 20, 2025 | globenewswire.comCreative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To ProfitMarch 16, 2025 | finance.yahoo.comCreative Medical announces agreements for exercise of warrantsMarch 6, 2025 | markets.businessinsider.comCreative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross ProceedsMarch 6, 2025 | markets.businessinsider.comCreative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross ProceedsMarch 6, 2025 | globenewswire.comCreative Medical Technology comments on presidential initiative for IVF accessFebruary 20, 2025 | markets.businessinsider.comCreative Medical announces mid-term follow-up study data from StemSpine studyFebruary 14, 2025 | markets.businessinsider.comCreative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™February 14, 2025 | globenewswire.comCreative Medical reports progress in Type 2 Diabetes treatmentFebruary 11, 2025 | msn.comCreative Medical Technology reports one-year results for AlloStem programFebruary 11, 2025 | markets.businessinsider.comCreative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes ProgramFebruary 11, 2025 | globenewswire.comCreative Medical enhances diabetes treatment with AI techFebruary 6, 2025 | msn.comCreative Medical Technology Holdings (CELZ): AI-Enhanced Stem Cell Therapy for DiabetesFebruary 5, 2025 | insidermonkey.comCreative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline DevelopmentFebruary 5, 2025 | globenewswire.comCreative Medical reports data from first cohort in Phase 1/2 CELZ-201-DDT trialJanuary 31, 2025 | markets.businessinsider.comCreative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back PainJanuary 30, 2025 | globenewswire.comCreative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain TreatmentNovember 13, 2024 | globenewswire.comCreative Medical Technology Holdings Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.02 loss in 3Q 2023)November 11, 2024 | uk.finance.yahoo.comCreative Medical Technology files to sell 837,104 shares of common for holdersNovember 10, 2024 | markets.businessinsider.comCreative Medical Technology files to sell 0.83M shares of common stocks by selling shareholdersNovember 10, 2024 | msn.comCreative Medical to sell 418,552 shares at $4.42 in registered direct offeringOctober 24, 2024 | finance.yahoo.comCreative Medical Technology to raise $1.9M via direct offeringOctober 23, 2024 | msn.comCreative Medical Tech (NASDAQ:CELZ) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comCreative Medical Tech (NASDAQ:CELZ) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comCreative Medical Technology files for $50M mixed securities shelfOctober 4, 2024 | msn.comCreative arts therapy programs can help health care workers through burnout and on-the-job stressAugust 30, 2024 | msn.comBrain-Imaging Experiment Reveals The Secret Behind Creative FlowAugust 16, 2024 | msn.comCELZ Stock Earnings: Creative Medical Tech Misses EPS for Q2 2024August 12, 2024 | investorplace.comCreative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine ProgramJuly 24, 2024 | globenewswire.comCreative Medical Technology Holdings Provides Corporate UpdateJuly 10, 2024 | globenewswire.comCreative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human InsulinJune 24, 2024 | globenewswire.comCreative Medical Technology Holdings Inc CELZApril 24, 2024 | morningstar.comM Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CELZ Media Mentions By Week CELZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CELZ News Sentiment▼1.920.93▲Average Medical News Sentiment CELZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CELZ Articles This Week▼10▲CELZ Articles Average Week Get the Latest News and Ratings for CELZ and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Creative Medical Technology and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies OnKure Therapeutics News BioAtla News LAVA Therapeutics News Elutia News Klotho Neurosciences News BioXcel Therapeutics News Verrica Pharmaceuticals News Mural Oncology News X4 Pharmaceuticals News Iterum Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CELZ) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CELZ Stock Alerts